🇺🇸 FDA
Patent

US 11673867

Sulfonamide derivative or pharmaceutically acceptable acid-addition salt

granted A61KA61K9/0053A61P

Quick answer

US patent 11673867 (Sulfonamide derivative or pharmaceutically acceptable acid-addition salt) held by The Board of Regents of the University of Texas System expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K9/0053, A61P, A61P25/00